Antabuse Related Published Studies
Well-designed clinical trials related to Antabuse (Disulfiram)
Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. [2011.01.15]
Randomized, double blind, placebo-controlled trial of disulfiram for the
treatment of cocaine dependence in methadone-stabilized patients. [2011]
Effect of the threat of a disulfiram-ethanol reaction on cue reactivity in alcoholics. [2010.12.01]
Disulfiram in severe alcoholism--an open controlled study. [2010.12]
Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. [2010.09.07]
A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence. [2008.05]
A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. [2008.01]
Naltrexone and disulfiram in patients with alcohol dependence and current depression. [2007.04]
Disulfiram effects on responses to intravenous cocaine administration. [2007.03.16]
Short-term efficacy of Disulfiram or Naltrexone in reducing positive urinalysis for both cocaine and cocaethylene in cocaine abusers: A pilot study. [2007.02]
Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. [2006.10.01]
Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram. [2006.10]
Disulfiram and low nickel diet in the management of hand eczema: a clinical study. [2006.03]
An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. [2005.11]
Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. [2005.05.15]
A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. [2004.11]
Cost effectiveness of disulfiram: treating cocaine use in methadone-maintained patients. [2004.04]
Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. [2004.03]
Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. [2003.09]
One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. [2000.09]
Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. [2000.06.15]
Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts. [2000.02]
Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1. [1999.06]
Disulfiram effects on acute cocaine administration. [1998.09.01]
Single-dose disulfiram does not inhibit CYP2A6 activity. [1998.07]
Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. [1998.05]
Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. [1998.05]
Chronic disulfiram treatment effects on intranasal cocaine administration: initial results. [1998.04.01]
An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation--a VA cooperative study. [1996.07.15]
Can disulfiram potentiate the dexamethasone suppression test in depressive patients? [1993.08]
Disulfiram treatment of alcoholism. [1992.07]
Lack of bioequivalence between disulfiram formulations. Exemplified by a tablet/effervescent tablet study. [1992]
Disulfiram implant: a double-blind placebo controlled follow-up on treatment outcome. [1991.06]
A randomized phase II study of cisplatin alone versus cisplatin plus disulfiram. [1990.04]
A double-blind placebo controlled study of healthy volunteers given a subcutaneous disulfiram implantation. [1990.03]
Lack of immunomodulating effect of disulfiram on HIV positive patients. [1990]
Alcohol-induced bone marrow damage: status before and after a 4-week period of abstinence from alcohol with or without disulfiram. A randomized bone marrow study in alcohol-dependent individuals. [1989.09]
Dose-dependent inhibition of theophylline metabolism by disulfiram in recovering alcoholics. [1989.05]
Cefotetan-induced disulfiram-type reactions and hypoprothrombinemia. [1987.09]
Well-designed clinical trials possibly related to Antabuse (Disulfiram)
The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid axis I disorders. [2007.11]
Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland. [2007.07]
Comparing treatments of alcoholism on craving and biochemical measures of alcohol consumptionst. [2006.09]
Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia. [2004.03]
The URICA as a measure of motivation to change among treatment-seeking individuals with concurrent alcohol and cocaine problems. [2002.12]
Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. [2001.09]
Contribution of CYP2E1 and CYP3A to acetaminophen reactive metabolite formation. [2000.03]
Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4. [2000.02]
Factors associated with compliance of alcoholics in outpatient treatment. [2000.02]
Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. [1999.05.15]
Pharmacological treatment of alcohol dependence: a review of the evidence. [1999.04.14]
Clinical isoflurane metabolism by cytochrome P450 2E1. [1999.03]
Traditional and western healing practices for alcoholism in American Indians and Alaska Natives. [1998.11]
Couples relapse prevention sessions after behavioral marital therapy for male alcoholics: outcomes during the three years after starting treatment. [1998.07]
Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis. [1996.05.18]
Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation. [1995.06]
Clinical enflurane metabolism by cytochrome P450 2E1. [1994.04]
Imipramine treatment of alcoholism with comorbid depression. [1993.06]
Lack of interaction between cefpirome and alcohol. [1992.04]
Acamprosate appears to decrease alcohol intake in weaned alcoholics. [1990]
4-Methylpyrazole: a controlled study of safety in healthy human subjects after single, ascending doses. [1988.08]
Other research related to Antabuse (Disulfiram)
[Meta-analysis of pharmacological therapy with acomprosate, naltrexone, and disulfiram - a systematic review.] [2011.11.28]
The efficacy of disulfiram for the treatment of alcohol use disorder. [2011.10]
Long-term gamma-hydroxybutyric acid (GHB) and disulfiram combination therapy in GHB treatment-resistant chronic alcoholics. [2011.07]
Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation. [2011.06]
Anti-inflammatory potency of oral disulfiram compared with dexamethasone on endotoxin-induced uveitis in rats. [2011.04]
Targeting malignancies with disulfiram (Antabuse): multidrug resistance, angiogenesis, and proteasome. [2011.03]
Disulfiram, and disulfiram derivatives as novel potential anticancer drugs targeting the ubiquitin-proteasome system in both preclinical and clinical studies. [2011.03]
Urinary ethylglucuronide assessment in patients treated with disulfiram: a tool to improve verification of abstention and safety. [2010.11]
Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine beta-hydroxylase. [2010.11]
Inhibitory effects of oral disulfiram on endotoxin-induced uveitis in rats. [2010.10]
Effect of the threat of a disulfiram-ethanol reaction on cue reactivity in alcoholics. [2010.08.12]
Severe hypotension and ischemic stroke after disulfiram-ethanol reaction. [2010.07]
Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients. [2010.05]
The use of disulfiram for alcohol-dependent patients and duration of outpatient treatment. [2010.04]
Disulfiram in severe alcoholism-an open controlled study. [2010.03.18]
Disulfiram impairs the development of behavioural sensitization to the stimulant effect of ethanol. [2010.03.05]
Disulfiram: an old therapeutic with new applications. [2010.03]
Supervised disulfiram in relapse prevention in alcohol-dependent patients suffering from comorbid borderline personality disorder--a case series. [2010.03]
Disulfiram for the treatment of cocaine dependence. [2010.01.20]
Reduction in intraocular pressure by the instillation of eye drops containing disulfiram included with 2-hydroxypropyl-beta-cyclodextrin in rabbit. [2010]
Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. [2010]
Disulfiram in severe alcoholism--an open controlled study. [2010]
Disulfiram for the treatment of cocaine dependence. [2010]
Suppressing glioblastoma stem cell function by aldehyde dehydrogenase inhibition with chloramphenicol or disulfiram as a new treatment adjunct: an hypothesis. [2009.12]
Disulfiram-like reaction with ornidazole. [2009.10]
Delayed and prolonged coma after acute disulfiram overdose. [2009.09]
mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. [2009.08]
Fatal lactic acidosis precipitated by nifedipine in a patient treated with disulfiram and antiretrovirals. [2009.08]
Cardiogenic shock caused by disulfiram. [2009.03]
Ritonavir and disulfiram have potential to inhibit caspase-1 mediated inflammation and reduce neurological sequelae after minor blast exposure. [2009.02]
Acute vocal fold palsy after acute disulfiram intoxication. [2009.01]
Acute myocardial infarction associated with disulfiram-alcohol interaction in a young man with normal coronary arteries. [2009.01]
Disulfiram-like syndrome after hydrogen cyanamide professional skin exposure: two case reports in France. [2009]
Disulfiram reduces elevated blood glucose levels in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of type 2 diabetes. [2009]
[Influence of disulfiram on the expression of transforming growth factor-beta2 in form-deprived eyes in chicks.] [2008.12.18]
Disulfiram enhances subjective effects of dextroamphetamine in humans. [2008.09]
The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhibitor? [2008.08]
The safety of disulfiram for the treatment of alcohol and cocaine dependence in randomized clinical trials: guidance for clinical practice. [2008.07]
Tolerance to disulfiram induced by chronic alcohol intake in the rat. [2008.06]
Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures. [2008.06]
An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence. [2008.06]
|
